Ramipril

   
Google
 
Web NewDrugInformation.com

Ramipril


Drug - Ramipril
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ramipril
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Ramipril. May repeat for multiple part products.

Applicant - COBALT
The firm name holding legal responsibility for Ramipril. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076549
The FDA assigned number to Ramipril. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Ramipril. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 24, 2005
The date Ramipril was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ramipril. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ramipril is in. Format is RX, OTC, DISCN.

Applicant Full Name - Cobalt Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Ramipril.

Ramipril